Samlyn Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,306,491
| Closed | -$77.3M | – | 111 |
|
|
2021
Q3 | $77.3M | Sell |
1,306,491
-568,213
| -30% | -$33.6M | 1.03% | 25 |
|
|
2021
Q2 | $125M | Buy |
1,874,704
+307,938
| +20% | +$20.6M | 1.84% | 16 |
|
|
2021
Q1 | $98.9M | Buy |
1,566,766
+59,678
| +4% | +$3.77M | 1.37% | 25 |
|
|
2020
Q4 | $93.5M | Buy |
1,507,088
+770,667
| +105% | +$47.8M | 1.34% | 17 |
|
|
2020
Q3 | $44.4M | Buy |
736,421
+234,653
| +47% | +$14.1M | 0.8% | 44 |
|
|
2020
Q2 | $29.5M | Buy |
+501,768
| New | +$29.5M | 0.55% | 55 |
|
|
2020
Q1 | – | Sell |
-763,174
| Closed | -$49M | – | 82 |
|
|
2019
Q4 | $49M | Sell |
763,174
-144,034
| -16% | -$9.25M | 1.03% | 33 |
|
|
2019
Q3 | $46M | Sell |
907,208
-296,071
| -25% | -$15M | 1.12% | 29 |
|
|
2019
Q2 | $54.6M | Buy |
1,203,279
+836,027
| +228% | +$37.9M | 1.15% | 27 |
|
|
2019
Q1 | $17.5M | Sell |
367,252
-127,107
| -26% | -$6.06M | 0.41% | 59 |
|
|
2018
Q4 | $25.7M | Buy |
+494,359
| New | +$25.7M | 0.61% | 49 |
|